91亚色传媒

News

Structure of the key protein for an HCV vaccine

Lisa Eshun鈥揥ilson Alba Torrents de la Peña
By Lisa Eshun鈥揥ilson and Alba Torrents de la Pe帽a
Dec. 18, 2022

The , causes a chronic liver infection that can lead to permanent liver scarring and, in dire cases, cancer. It affects around and causes approximately 400,000 deaths each year. While for HCV-related infections, they are expensive, hard to access and do not protect against reinfection. A vaccine that can help prevent HCV infection is a major unmet medical and public health need.

One major reason there hasn’t been an HCV vaccine yet is that scientists have yet to identify the proper antigen, or the part of the virus would trigger a protective immune response in the body.

Decades of research have pinpointed , the only protein on the surface of the virus, as the most promising vaccine candidate. However, developing an HCV vaccine based on that protein is limited by uncertainty around what it looks like. Knowing the structure of the protein is necessary to figure out how the immune system responds to the virus.

So how do researchers capture the structure of single protein on a shape-shifting virus?

We are researchers who specialize in and . With new technology, we were able to of this elusive protein, unlocking key insights into how this virus works and offering a potential blueprint for a future vaccine.

This is how we did it.

Challenges of capturing a shape-shifting virus

One reason it has been so difficult to capture the structure of the HCV E1E2 protein is that it is both . It changes its shape so often and is so easily broken that it’s challenging to purify.

As an analogy, imagine a bowl of spaghetti drenched in tomato sauce. Now imagine trying to take a picture of each individual piece of spaghetti in the same position over time while the bowl is shaking. Hard to do, right? That’s what it was like to image the full E1E2 protein.

There were also . Until recently, available imaging techniques were limited in their ability to view microscopic proteins. , for instance, is unable to capture molecules that frequently change and shape-shift, like HCV. Moreover, other options, such as , required cutting large parts of the protein or chemically manipulating it in a way that would transform its physiological state and potentially alter its function.

So to examine the structure of E1E2, we needed a way to extract and purify, stabilize and trap the entire shape-shifting protein into one configuration.

How to take a picture of protein

, is a type of imaging technique that views specimens at cryogenic temperatures, in this case the boiling point of nitrogen: minus 320.8 degrees Fahrenheit (minus 196 Celsius). With temperatures that cold, ice freezes so quickly that it doesn’t have time to crystallize. That creates a beautiful glasslike frame around the protein of interest, allowing an unhindered view of every structural detail. Cryo-EM also requires very little protein to work, reducing the amount of material we would need to purify.

Winner of the and ” award, cryo-EM is superb for imaging biological macromolecules in their native, or natural, state in the aqueous environment of human blood. Cryo-EM was also pivotal for characterizing the and its variants.

Cryo-EM has allowed researchers to see complex proteins they weren’t able to before.

So how do you take a picture of a protein?

First, we embedded the genetic code to make E1E2 in human cells in a petri dish so we would have sufficient amounts of protein to study. After purifying the protein, we followed by liquid nitrogen. Liquid ethane is used to freeze the protein because it has a higher boiling point than liquid nitrogen. This means it is able to capture more heat before turning to a gas, allowing the protein to freeze much more quickly than it would in liquid nitrogen and avoid structural damage.

Once the protein was vitrified, or in a glasslike ice state, we were able not just to see its overall structure, but also to capture multiple individual configurations of the protein that it takes when it shape-shifts, including its less stable forms.

At this point, our protein was ready for its close-up. We employed a microscope that and a very fancy camera that detects how the elections bounce off the protein’s surface. This created a 2D image that we then mathematically transformed into a 3D model. And that was how we got the coveted “close-up” of HCV’s surface protein.

This video shows the newly identified 3D structure of the E1E2 protein on the surface of the hepatitis C virus. The two main subunits of the protein are colored in pink and blue. Sugar molecules are colored in green.

Our next step was then to assess the location of each amino acid, or building block of the protein, in 3D space. Because every amino acid has a unique shape, we used a computer program that could identify each one in our 3D map. This allowed us to manually reconstruct a high-resolution model of the protein, one building block at a time.

A new tool to design an HCV vaccine

Our 3D map and model of the HCV E1E2 protein supports previous research describing its structure while providing new insights into features that will help pave the way for a long-sought vaccine design against this virus.

For example, our structure reveals that the interface between the two main parts of the protein is stabilized by sugars and hydrophobic patches, or areas that push out water molecules. This creates sticky binding hubs along the protein and keeps it from falling apart – a potential site for protective antibodies and new drugs to target.

Researchers now have the tools to design antiviral drugs and vaccines against HCV infection.

This article is republished from under a Creative Commons license. Read the .

The Conversation

Enjoy reading 91亚色传媒 Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Lisa Eshun鈥揥ilson
Lisa Eshun鈥揥ilson

Lisa Eshun鈥揥ilson is a postdoctoral scholar in molecular and cell biology at The Scripps Research Institute.

Alba Torrents de la Peña
Alba Torrents de la Peña

Alba Torrents de la Pe帽a is a postdoctoral fellow in integrative structural and computational biology at The Scripps Research Institute.

Get the latest from 91亚色传媒 Today

Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

New discovery enables gene therapy for muscular dystrophies, other disorders
News

New discovery enables gene therapy for muscular dystrophies, other disorders

Dec. 28, 2024

At the University of Rochester, researchers find that RNA-based technology facilitates effective use for difficult-to-treat, large-gene diseases.

From the journals: JBC
Journal News

From the journals: JBC

Dec. 27, 2024

Huntington protein interactions affect aggregation. Intrinsically disordered protein forms a scaffold. From unknown protein to curbing cancer growth. Read about recent JBC papers on these topics.

An inclusive solar eclipse 鈥 with outreach
Essay

An inclusive solar eclipse 鈥 with outreach

Dec. 26, 2024

Traveling more than 150 miles with a group of neurodivergent students to have them witness a rare orbital alignment. and also teach the public about it, requires some strategic planning.

Predicting fatty liver disease from a tiny blood sample
Journal News

Predicting fatty liver disease from a tiny blood sample

Dec. 24, 2024

Obesity and being overweight aren't the only factors that contribute to liver disease. New tests can help identify who is at risk or already has the disease, even in people who are lean or have a normal weight.

An ancient animal helps scientists improve modern technology
News

An ancient animal helps scientists improve modern technology

Dec. 22, 2024

The same molecules that help tardigrades survive extreme weather can improve cryo-EM images of cellular structures and proteins, a team led by University of Wisconsin鈥揗adison researcher Ci Ji Lim reports.

New structure gives insight into mRNA export and cancers
News

New structure gives insight into mRNA export and cancers

Dec. 21, 2024

Yi Ren鈥檚 lab at Vanderbilt has described the structure of a protein complex that sheds light on the underlying molecular mechanism of mRNA export.